Atraric acid

Source: Wikipedia, the free encyclopedia.
Atraric acid
Names
Preferred IUPAC name
Methyl 2,4-dihydroxy-3,6-dimethylbenzoate
Other names
Veramoss, Evernyl
Identifiers
3D model (
JSmol
)
ChemSpider
ECHA InfoCard
100.022.902 Edit this at Wikidata
UNII
  • InChI=1S/C10H12O4/c1-5-4-7(11)6(2)9(12)8(5)10(13)14-3/h4,11-12H,1-3H3
    Key: UUQHKWMIDYRWHH-UHFFFAOYSA-N
  • Cc1cc(c(c(c1C(=O)OC)O)C)O
Properties
C10H12O4
Molar mass 196.202 g·mol−1
Melting point 143–145 °C (289–293 °F; 416–418 K)[1]
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).

Atraric acid is a naturally occurring

benign prostate hyperplasia, prostate cancer, and spinal and bulbar muscular atrophy has been investigated.[2]

References

  1. .
  2. ^ a b US application 20090143466, Aria Baniahmad; Hans-Rainer Hoffmann & Rudolf Matusch, "Isolation of Atraric Acid, Synthesis of Atraric Acid Derivatives, and Use of Atraric Acid and the Derivatives Thereof for the Treatment of Benign Prostatic Hyperplasia, Prostate Carcinoma and Spinobulbar Muscular Atrophy", published 2009-06-04, assigned to Aria Baniahmad and Hans-Rainer Hoffmann, Rudolf Matusch 
  3. ^ .

Other sources